NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 762 filers reported holding NOVARTIS A G in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $21,000 | +61.5% | 220 | +46.7% | 0.00% | +100.0% |
| Q3 2020 | $13,000 | +85.7% | 150 | +87.5% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | 0.0% | 80 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | -73.1% | 80 | -73.3% | 0.00% | -90.0% |
| Q4 2015 | $26,000 | -7.1% | 300 | 0.0% | 0.01% | +11.1% |
| Q3 2015 | $28,000 | -68.5% | 300 | -66.7% | 0.01% | -66.7% |
| Q2 2015 | $89,000 | 0.0% | 900 | 0.0% | 0.03% | +17.4% |
| Q1 2015 | $89,000 | +7.2% | 900 | 0.0% | 0.02% | +9.5% |
| Q4 2014 | $83,000 | -2.4% | 900 | 0.0% | 0.02% | -22.2% |
| Q3 2014 | $85,000 | +4.9% | 900 | 0.0% | 0.03% | +50.0% |
| Q2 2014 | $81,000 | +5.2% | 900 | 0.0% | 0.02% | -18.2% |
| Q1 2014 | $77,000 | +6.9% | 900 | 0.0% | 0.02% | +4.8% |
| Q4 2013 | $72,000 | -80.1% | 900 | -80.9% | 0.02% | -80.4% |
| Q3 2013 | $361,000 | +464.1% | 4,700 | +422.2% | 0.11% | +409.5% |
| Q2 2013 | $64,000 | – | 900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |